- CEO of Covid antibody maker Vir Biotech says their treatment 'stands up well' to all variants CNBC
- US signs $1 billion deal for COVID-19 antibody drug The Jerusalem Post
- Glaxo, Vir Report $1 Billion Sale for Covid-19 Antibody. U.S. Is Still Buying. Barron's
- U.S. secures GSK-Vir COVID-19 antibody therapy doses worth $1 bln Reuters
- U.S. Boosts Order for Glaxo’s Covid-19 Antibody Drug The Wall Street Journal
- View Full Coverage on Google News
source https://news.google.com/__i/rss/rd/articles/CBMigAFodHRwczovL3d3dy5jbmJjLmNvbS8yMDIxLzExLzE3L2Nlby1vZi1jb3ZpZC1hbnRpYm9keS1tYWtlci12aXItYmlvdGVjaC1zYXlzLXRoZWlyLXRyZWF0bWVudC1zdGFuZHMtdXAtd2VsbC10by1hbGwtdmFyaWFudHMuaHRtbNIBhAFodHRwczovL3d3dy5jbmJjLmNvbS9hbXAvMjAyMS8xMS8xNy9jZW8tb2YtY292aWQtYW50aWJvZHktbWFrZXItdmlyLWJpb3RlY2gtc2F5cy10aGVpci10cmVhdG1lbnQtc3RhbmRzLXVwLXdlbGwtdG8tYWxsLXZhcmlhbnRzLmh0bWw?oc=5
عن الكاتب
ELQISER
script full nulled
ضع تعليقك
ملحوظة: يمكن لأعضاء المدونة فقط إرسال تعليق.